SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-19-010059
Filing Date
2019-09-04
Accepted
2019-09-04 16:19:43
Documents
1
Period of Report
2019-09-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3415
  Complete submission text file 0001179110-19-010059.txt   4853
Mailing Address C/O NXSTAGE MEDICAL INC. (NXTM) 439 SOUTH UNION STREET, 5TH FLOOR LAWRENCE MA 01843
Business Address
GILL DAVID N (Reporting) CIK: 0001106519 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37569 | Film No.: 191074781

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Issuer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
SIC: 2834 Pharmaceutical Preparations